“Bebelucy,” an artificial intelligence (AI) smart baby bed of Emma Healthcare (CEO Son Yang-hee), a digital healthcare company based on advanced medical engineering technology, won the innovation award at “CES 2022,” the world’s largest electronic exhibition.
IoT-based “Bebelucy” is an artificial intelligence-based smart baby crop that allows guardians to monitor biological signals such as baby’s body temperature, heartbeat, and respiratory rate through a dedicated application.
Image-based artificial intelligence technology, which is a non-contact signal, monitors not only the baby’s bio-signal but also environmental information such as ambient temperature, humidity, and air quality, and communicates with indoor appliances (air purifiers, air conditioners) to maintain and control the optimal environment.
In addition, it is equipped with a sleep-inducing motion function that can help babies sleep, and a function that promotes brain development of infants and toddlers after childbirth by recording a mother’s heart rate during pregnancy and using it as white noise.
Services provided by artificial intelligence (AI) startups that have emerged through niche markets to scratch users and companies’ “crisis” are very popular.
In particular, as if proving that “Korean DNA” flows, places that focus on developing innovative technologies that incorporate artificial intelligence so that services can be used quickly and efficiently at once are drawing attention. Smart AI one-stop services that simplify the complex steps that have spanned several procedures are now leading the market.
Thanks to this, the stage for active activities is also expanding by providing convenient one-stop services from e-commerce to store operation, medical care, law, travel, and content production.
Emma Healthcare, which secures unrivaled competitiveness by introducing AI technology that innovates the market and increases convenient experiences for users and companies by reducing cumbersome procedures, is a third-class medical device, and soft bio-cold plasma wellness device that has obtained European CE certification and US FDA certification.It was.
In addition, CEO Sohn Yang-hee will meet visitors through a seminar on the 29th following the 27th on the “development of smart healthcare medical technology that can diagnose vascular cognitive impairment (dementia) through advanced artificial intelligence vascular analysis” that is being promoted with new projects in 2020.
A company official said, “If Emma Healthcare’s smart healthcare medical devices are activated, customized medical services will be available through continuous monitoring of the health status of chronically ill patients suffering from high blood pressure, diabetes, heart disease, and brain lesions, and smart technology will be applied anytime, anywhere.”
In addition, he added, “More than 90% of elderly patients are chronically ill, and more than half (51%) of the elderly aged 65 or older have more than three chronic diseases, so the ripple effect of senior care and chronic disease management, especially those living alone, will be greater.
▲ Emma Healthcare Co., Ltd
▲ CEO: Daniel Sohn
▲ Brand : PlaLucy
▲ www.Emmahc.com
▲ sales@emmahc.com / chief@emmahc.com
▲ 82-70-4422-0101
Sam Kim
Asia Journal
